Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 527-532

  Voet, Arnout ^a   Callewaert, Lien ^b   Ulens, Tim ^a   Vanderkelen, Lise ^b   Vanherreweghe, Joris M ^b   Michiels, Chris W ^b   De Maeyer, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEUVEN FOOD SCIENCE AND NUTRITION RESEARCH CENTRE LFORCE   (Belgium)

Author keywords

Docking; Drug design; MliC; Pharmacophore; PliC; Salmonella; SMPPII

Indexed keywords

GLYCOSIDASE INHIBITOR; LYSOZYME; LYSOZYME INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SALMONELLA TYPHIMURIUM;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMPUTER SIMULATION; DRUG DISCOVERY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MURAMIDASE; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 79951946086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.053     Document Type: Article

References (34)

1. Callewaert L., Michiels C.W. Lysozymes in the animal kingdom. J. Biosci. 2010, 35:127-160.
2. Markart P., Korfhagen T.R., Weaver T.E., Akinbi H.T. Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Am. J. Respir. Crit. Care Med. 2004, 169:454-458.
3. Akinbi H.T., Epaud R., Bhatt H., Weaver T.E. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J. Immunol. 2000, 165:5760-5766.
4. Cole A.M., Thapa D.R., Gabayan V., et al. Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M. J. Leukoc. Biol. 2005, 78:1081-1085.
5. Phillips D.C. Crystallographic studies of enzymic properties of lysozyme. Acta Crystallogr. 1966, 21:A163.
6. Malcolm B.A., Rosenberg S., Corey M.J., et al. Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg-white lysozyme. Proc. Natl. Acad. Sci. USA 1989, 86:133-137.
7. Boneca I.G., Dussurget O., Cabanes D., et al. A critical role for peptidoglycan N-deacetylation in listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. USA 2007, 104:997-1002.
8. Bera A., Biswas R., Herbert S., Gotz F. The presence of peptidoglycan O-acetyltransferase in various Staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect. Immun. 2006, 74:4598-4604.
9. Monchois V., Abergel C., Sturgis J., et al. Claverie, Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J. Biol. Chem. 2001, 276:18437-18441.
10. Callewaert L., Aertsen A., Deckers D., et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog. 2008, 4:e1000019.
11. Van Herreweghe J.M., Vanderkelen L., Callewaert L., et al. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme. Cell Mol. Life Sci. 2010, 67:1177-1188.
12. L. Vanderkelen, J.M. Van Herreweghe, K.G. Vanoirbeek, et al. Identification of a bacterial inhibitor against g-type lysozyme, Cell Mol. Life Sci. (2010) doi 10.1007/s00018-010-0507-3.
13. Abergel C., Monchois V., Byrne D., et al. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in gram-negative bacteria. Proc. Natl. Acad. Sci. USA 2007, 104:6394-6399.
14. Deckers D., Vanlint D., Callewaert L., et al. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk. Appl. Environ. Microbiol. 2008, 74:4434-4439.
15. Daigle F., Graham J.E., Curtiss R. Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences, SCOTS. Mol. Microbiol. 2001, 41:1211-1222.
16. Humann J., Lenz L.L. Bacterial peptidoglycan-degrading enzymes and their impact on host muropeptide detection. J. Innate Immun. 2009, 1:88-97.
17. Park J.W., Kim C.H., Kim J.H., et al. Clustering of peptidoglycan recognition protein-SA is required for sensing lysine-type peptidoglycan in insects. Proc. Natl. Acad. Sci. USA 2007, 104:6602-6607.
18. Cloud-Hansen K.A., Peterson S.B., Stabb E.V., et al. Breaching the great wall: peptidoglycan and microbial interactions. Nat. Rev. Microbiol. 2006, 4:710-716.
19. Yum S., Kim M.J., Xu Y., et al. Structural basis for the recognition of lysozyme by MliC, a periplasmic lysozyme inhibitor in gram-negative bacteria. Biochem. Biophys. Res. Commun. 2009, 378:244-248.
20. Deckers D., Masschalck B., Aertsen A., et al. Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli. Cell Mol. Life Sci. 2004, 61:1229-1237.
21. Laskowski R.A., Macarthur M.W., Moss D.S., Thornton J.M. Procheck - a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
22. Bostrom J., Greenwood J.R., Gottfries J. Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J. Mol. Graph. Model. 2003, 21:449-462.
23. Goodford P.J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28:849-857.
24. Jones G., Willett P., Glen R.C., et al. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267:727-748.
25. Eldridge M.D., Murray C.W., Auton T.R., et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput. Aided Mol. Des. 1997, 11:425-445.
26. Callewaert L., Masschalck B., Deckers D., et al. Purification of Ivy, a lysozyme inhibitor from Escherichia coli, and characterisation of its specificity for various lysozymes. Enzyme Microb. Technol. 2005, 205-211.
27. Nakimbugwe D., Masschalck B., Deckers D., et al. Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts. FEMS Microbiol. Lett. 2006, 259:41-46.
28. Berg T. Modulation of protein-protein interactions with small organic molecules. Angew. Chem., Int. Ed. Engl. 2003, 42:2462-2481.
29. Pagliaro L., Felding J., Audouze K., et al. Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr. Opin. Chem. Biol. 2004, 8:442-449.
30. Yin H., Hamilton A.D. Strategies for targeting protein-protein interactions with synthetic agents. Angew. Chem., Int. Ed. Engl. 2005, 44:4130-4163.
31. Berg T. Small-molecule inhibitors of protein-protein interactions. Curr. Opin. Drug Discov. Devel. 2008, 11:666-674.
32. Fry D.C. Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry. Curr. Protein Pept. Sci. 2008, 9:240-247.
33. Bourgeas R., Basse M.J., Morelli X., Roche P. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database. PLoS One 2010, 5:e9598.
34. Christ F., Voet A., Marchand A., et al. Nat. Chem. Biol. 2010, 6:442-448.